papillary RCC

• 

ASCO 2020: Savolitinib is promising for the treatment of papillary renal cell carcinoma

By Sharon Kell|2020-06-01T09:24:52+00:001 Jun 2020|Uncategorized|

In a study presented during the 2020 American Society of [...]

Read More

Comments Off on ASCO 2020: Savolitinib is promising for the treatment of papillary renal cell carcinoma

• 

Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma

By Sharon Kell|2020-04-06T10:00:28+00:006 Apr 2020|Uncategorized|

In this video interview from Practice Update, Dr Brad McGregor [...]

Read More

Comments Off on Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma

• 

Nivolumab for the treatment of metastatic non-clear cell renal cell carcinoma

By Sharon Kell|2020-03-25T09:40:03+00:0025 Mar 2020|Uncategorized|

Nivolumab alone and in combination with ipilimumab is used for [...]

Read More

Comments Off on Nivolumab for the treatment of metastatic non-clear cell renal cell carcinoma

• 

Axitinib first-line treatment of papillary renal cell carcinoma

By Sharon Kell|2020-03-17T12:12:14+00:0017 Mar 2020|Drug treatments|

The majority of renal cell carcinomas (RCCs) are a subtype [...]

Read More

Comments Off on Axitinib first-line treatment of papillary renal cell carcinoma

• 

ASCO GU 2020: Overall survival results for savolitinib and durvalumab in papillary kidney cancer

By Sharon Kell|2020-02-21T15:05:41+00:0021 Feb 2020|Drug treatments|

Overall survival results from a study with a combination of [...]

Read More

Comments Off on ASCO GU 2020: Overall survival results for savolitinib and durvalumab in papillary kidney cancer

• 

First-line treatment of papillary renal cell carcinoma with sunitinib

By Sharon Kell|2020-02-13T08:54:17+00:0013 Feb 2020|Drug treatments|

Papillary renal cell carcinoma (PRCC) is a rare subtype of [...]

Read More

Comments Off on First-line treatment of papillary renal cell carcinoma with sunitinib

• 

Prognosis of type 1 and type 2 papillary renal cell carcinoma

By Sharon Kell|2020-02-05T17:14:08+00:005 Feb 2020|Cancer news|

In a recent analysis of a large database, researchers compared [...]

Read More

Comments Off on Prognosis of type 1 and type 2 papillary renal cell carcinoma

• 

VENUSS prognostic model for papillary kidney cancer

By Sharon Kell|2019-10-18T08:39:52+00:0018 Oct 2019|Subtypes of RCC|

A recent study published in BMC Medicine this month investigates [...]

Read More

Comments Off on VENUSS prognostic model for papillary kidney cancer

• 

ASCO 2019: First-line pembrolizumab for advanced kidney cancer

By Sharon Kell|2019-06-06T15:50:36+00:006 Jun 2019|Drug treatments|

Two presentations on the results of the KEYNOTE-427 clinical trial [...]

Read More

Comments Off on ASCO 2019: First-line pembrolizumab for advanced kidney cancer

• 

Savolitinib shows promise in first-in-human phase 1 study in solid tumours

By Sharon Kell|2019-05-07T13:50:24+00:007 May 2019|Drug treatments|

Results from a first-in-human phase 1 study of savolitinib in [...]

Read More

Comments Off on Savolitinib shows promise in first-in-human phase 1 study in solid tumours